Sunday, January 11, 2026
Commercialization Partnership Announced for Vizz in the Middle East
Lenz Therapeutics Inc. and Lunatus Marketing & Consulting FZCO announced an exclusive distribution agreement.
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://clspectrum.com/media/un2h5d3i/cls-jan26-cover.jpg
Contact Lens Spectrum
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://clspectrum.com/media/zf0kqy3n/combo-cover.jpg
Eyecare Business
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://clspectrum.com/media/av2hz0qm/jan-feb-cover.jpg
Optometric Management
Sunday, January 11, 2026
Lenz Therapeutics Inc. and Lunatus Marketing & Consulting FZCO announced an exclusive distribution agreement.
Friday, January 9, 2026
The lenses are built on technology exclusively licensed from the Brien Holden Vision Institute.
Friday, January 9, 2026
This brings axial length, full biometry, and autorefraction into one automated, child-friendly platform
Friday, January 9, 2026
The new lens combines the MiSight 1 day ActivControl Technology with silicone hydrogel material used in MyDay lenses, the company says.
Sunday, January 4, 2026
The Digest reflects a global expert consensus on the definitions, risk factors, prevention, and management of myopia in children and young adults.
Sunday, January 4, 2026
Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.